Sitostenone

• Description:

  Sitostenone has antioxidation activity. Stigmasta-4-en-3-one (Sitostenone) can be used for the treatment of androgen-dependent diseases, especially for the treatment of benign prostatic hyperplasia.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  412.7

• Molecular Formula:

  C29H48O

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  1058-61-3